keynote trial data: pembrolizumab’s role in nsclc
Published 6 years ago • 253 plays • Length 8:19Download video MP4
Download video MP3
Similar videos
-
1:48
results of keynote-024 trial of pembrolizumab in nsclc
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
5:54
pembrolizumab in newly diagnosed squamous nsclc
-
3:31
the keynote-024 precedent for advanced-nsclc treatment
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
5:00
implications for pembrolizumab in nsclc
-
1:18
dr. reck on the safety of pembrolizumab in keynote-024 in metastatic nsclc
-
4:47
benefit of pembrolizumab in nsclc: the keynote trials
-
4:05
pembrolizumab chemotherapy in newly diagnosed nsclc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
1:50
dr. levy discusses pembrolizumab in nsclc
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
2:04
dr. gandhi on pembrolizumab/chemo findings in nsclc and fda approval
-
3:07
the keynote-001 trial: a breakthrough for pembrolizumab
-
5:42
keynote-189: chemotherapy and pembrolizumab in mnsclc
-
0:54
dr. bestvina on the keynote-407 trial in squamous nsclc
-
2:44
pembrolizumab and chemotherapy in advanced nsclc
-
6:32
keynote trials show pembrolizumab benefited patients with advanced small cell lung cancer